Welcome to our dedicated page for Avepoint SEC filings (Ticker: AVPT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The AvePoint, Inc. (AVPT) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures, including current reports on Form 8-K and other key documents filed with the U.S. Securities and Exchange Commission. These filings offer detailed information about AvePoint’s financial results, capital markets activity, and material corporate events related to its role as a provider of data security, governance, and resilience solutions for SaaS and cloud collaboration platforms.
Investors can use AvePoint’s 8-K filings to review press releases that are furnished as exhibits, such as quarterly financial results and announcements about underwriting agreements and public offerings connected to the company’s listing on the Singapore Exchange. For example, AvePoint has filed Form 8-K reports to furnish its second and third quarter financial results and to disclose the underwriting agreement and offering terms associated with its SGX listing. These documents complement the company’s annual and quarterly reports on Forms 10-K and 10-Q, which contain broader discussions of financial condition, risk factors, and business operations.
The filings page also reflects corporate actions related to listing status. A Form 25 filing, for instance, documents the removal from listing and registration on Nasdaq of a class of AvePoint warrants under Section 12(b) of the Securities Exchange Act of 1934. Such filings help investors understand changes in how specific AvePoint securities trade and are registered.
On Stock Titan, AvePoint filings are paired with AI-powered summaries that explain the significance of each document in clear language. Users can quickly see the main points of earnings-related 8-Ks, offerings, and listing changes, while still having direct access to the full text on EDGAR. This combination of real-time updates, insider-relevant forms such as 8-K and 25, and AI-generated insights helps investors and analysts follow AvePoint’s regulatory history and ongoing disclosure practices more efficiently.
Form 4 overview
On 06/20/2025, AvePoint, Inc. (AVPT) Chief Legal Officer and director Brian Michael Brown reported an exempt disposition of 1,547 common shares (transaction code F) at a price of $17.96 per share. The shares were withheld by the issuer to satisfy income-tax obligations related to equity compensation under Rule 16b-3, so the filing does not reflect an open-market sale.
Following the transaction, Brown directly owns 1,260,443 AvePoint common shares. No derivative security activity was reported. The filing is administrative in nature and shows the insider maintains a substantial stake while meeting tax liabilities.
Form 4 filing overview: On 20 June 2025 AvePoint, Inc. (AVPT) filed a Form 4 disclosing that board director Jeff Epstein acquired additional equity in the company.
- Security: Common stock, reported as a mix of ordinary shares and restricted stock units (RSUs) issued under the 2021 Equity Incentive Plan.
- Amount acquired: 9,744 shares/RSUs.
- Transaction code: “A” (acquisition).
- Transaction price: $17.96 per share as listed in the filing.
- Post-transaction holding: 1,167,635 shares held directly by Mr. Epstein.
- Vesting schedule: 100 % of the RSUs will vest on 1 June 2026, contingent on continued service.
The filing indicates that the additional equity was granted rather than purchased on the open market, a typical element of director compensation. Nonetheless, it raises Mr. Epstein’s direct ownership to more than one million shares, aligning his interests with shareholders ahead of the scheduled vesting date in 2026.
AvePoint, Inc. (AVPT) – Form 4 insider filing
The filing reports that director Jeff Teper received an equity award on 20 June 2025. The grant consists of 9,744 restricted stock units (RSUs), each convertible into one share of common stock upon vesting. The RSUs carry a reference price of $17.96 and will vest 100 % on 1 June 2026, conditional on Teper’s continued service.
Following this award, Teper’s total beneficial ownership increased to 319,305 AVPT shares, held directly. No derivative securities, dispositions, or open-market purchases were disclosed.
The transaction reflects routine board compensation and represents roughly 0.1 % of AvePoint’s 206 million basic shares outstanding (based on latest 10-Q), implying an immaterial dilution impact.
Form 4 Overview – AvePoint, Inc. (AVPT)
Director Janet Schijns reported an equity transaction dated 20 June 2025. The filing shows the acquisition of 9,744 shares of AvePoint common stock (classified as restricted stock units, RSUs) at a stated price of $17.96 per share under the company’s 2021 Equity Incentive Plan. The RSUs represent a contingent right to receive one share of common stock for each unit upon vesting.
Vesting & Ownership
- 100 % of the RSUs vest on 1 June 2026, subject to the director’s continued service.
- Post-transaction beneficial ownership rises to 89,801 shares, held directly.
No derivative securities (options, warrants, etc.) were reported in Table II. The transaction was coded “A” (acquisition) and signed by Attorney-in-Fact Brian Michael Brown on 23 June 2025.
Investor Takeaways
- The filing indicates continued board-level alignment with shareholders through additional equity exposure.
- Because the award is in the form of RSUs rather than an open-market cash purchase, cash outlay by the insider is minimal; nevertheless, the grant’s delayed vesting may aid long-term retention.
AvePoint, Inc. (AVPT) filed a Form 4 disclosing that director John Chi On Ho received 9,744 shares of common stock in the form of restricted stock units (RSUs) on 20 June 2025 under the company’s 2021 Equity Incentive Plan. The transaction is coded “A,” indicating an acquisition rather than a disposition. The RSUs carry a grant date value that references a $17.96 share price, but no cash changed hands because the units were awarded, not bought on the open market.
Following the grant, Ho’s total beneficial ownership rose to 4,295,768 shares, reinforcing a substantial insider stake. Per the accompanying footnotes, 100% of these RSUs will vest on 1 June 2026, contingent on Ho’s continued service as a director. No derivative securities, options, or additional equity instruments were reported. The filing contains no information on company earnings, operations, or other material events; it is strictly a disclosure of insider equity compensation.
For investors, the award marginally increases insider alignment but is not large enough relative to the existing 4.3 million-share holding—or AvePoint’s overall float—to be considered materially dilutive or a strong buy signal. The absence of open-market purchases limits the direct market-sentiment read-through. Overall, the filing is routine and has limited impact on the investment thesis, though it confirms ongoing board engagement and adherence to compensation schedules.